Khazaal Yasser, Frésard Emmanuelle, Zimmermann Grégoire, Trombert Nathalie Morinière, Pomini Valentino, Grasset François, Borgeat François, Zullino Daniele
Department of Psychiatry-CHUV, University of Lausanne, Site de Cery, 1008 Prilly, Switzerland.
Clin Pract Epidemiol Ment Health. 2006 Oct 31;2:29. doi: 10.1186/1745-0179-2-29.
Patients with antipsychotic-induced weight gain (WG) regularly report on unsuccessful dietary trials, which suggests strong biological weight gain drive that is extremely hard to overcome with thoughts, such that behaviour doesn't change despite some intent to change. The purpose of the present study was to assess cognitions specifically related to restrained eating in severely overweight patients with schizophrenia treated with antipsychotic drugs.
Forty outpatients with schizophrenia and 40 controls without psychiatric disability were included. Both groups were composed of one subgroup severely overweight (defined as a BMI > 28), and a comparison sample (BMI<28). The revised version of the Mizes Anorectic cognitive questionnaire (MAC-R) was used in this cross-sectional case-control study.
Gender was significantly related to eating disorders cognition, women scoring higher than men. Patients with schizophrenia in general scored higher on the MAC-R total scale and on the MAC-R subscale 2, the latter score representing rigid weight regulation and fear of weight gain. When comparing the two groups of subjects with BMI < 28, it appeared that patients with schizophrenia also scored higher on MAC-R total scale, the subscales 2 and 3, the latter subscale 3, indicating altered self control and self-esteem.
As is the case in weight gain of subjects without schizophrenia, the present results suggest that the cognitive distortions, as assessed by the MAC-R, may play an important role in weight gain also in patients with schizophrenia, and in weight gain associated with antipsychotic pharmacotherapy. Particular attention to these processes may help to improve the management of antipsychotic drugs induced weight gain.
服用抗精神病药物导致体重增加(WG)的患者经常报告饮食控制尝试失败,这表明存在强烈的生理性体重增加驱动因素,这种因素极难通过思维克服,以至于尽管有改变的意图,但行为仍未改变。本研究的目的是评估与使用抗精神病药物治疗的重度超重精神分裂症患者的节制饮食具体相关的认知情况。
纳入40名精神分裂症门诊患者和40名无精神疾病的对照者。两组均由一个重度超重亚组(定义为体重指数>28)和一个对照样本(体重指数<28)组成。在这项横断面病例对照研究中使用了米兹厌食认知问卷修订版(MAC-R)。
性别与饮食失调认知显著相关,女性得分高于男性。总体而言,精神分裂症患者在MAC-R总量表和MAC-R子量表2上得分更高,后者得分代表严格的体重调节和对体重增加的恐惧。比较体重指数<28的两组受试者时,发现精神分裂症患者在MAC-R总量表、子量表2和3上得分也更高,后者子量表3表明自我控制和自尊改变。
与无精神分裂症患者的体重增加情况一样,目前的结果表明,通过MAC-R评估的认知扭曲在精神分裂症患者的体重增加以及与抗精神病药物治疗相关的体重增加中可能也起重要作用。对这些过程给予特别关注可能有助于改善对抗精神病药物所致体重增加的管理。